20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NeoGenomics, Inc. - (NEO) operates in the NASDAQ industry and is headquartered in Fort Myers, United States with about 2,500 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, NEO reported $727M in revenue and ($108M) in net income.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.
Interactive charts & full statements → Open the NEO valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $767M | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $244M | $100M | $87M | $66M | $60M | $43M | $34M | $29M | $20M | $12M | $6M |
| Gross Profit | $329M | $283M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $110M | $44M | $41M | $32M | $27M | $19M | $16M | $15M | $11M | $6M | $4M |
| Gross Margin % | 42.9% | 38.9% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | 46.0% | 42.4% | 45.2% | 43.8% | 46.8% | 47.8% | 44.8% | 44.7% | 45.9% | 51.6% | 53.3% | 52.0% | 57.4% |
| Operating Income (EBIT) | ($66M) | ($66M) | ($92M) | ($108M) | ($158M) | ($119M) | ($14M) | $13M | $10M | $3M | $3M | ($6M) | $2M | $3M | $1M | $0M | ($3M) | ($2M) | ($1M) | ($3M) | $0M |
| Operating Margin % | -8.6% | -9.1% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | 3.6% | 1.2% | 1.1% | -5.7% | 2.5% | 4.8% | 2.0% | -0.9% | -8.6% | -5.9% | -4.4% | -27.3% | 2.2% |
| Net Income | ($52M) | ($108M) | ($79M) | ($88M) | ($144M) | ($8M) | $4M | $8M | $3M | $0M | ($6M) | ($3M) | $1M | $2M | $0M | ($1M) | ($3M) | ($2M) | ($1M) | ($3M) | $0M |
| Net Margin % | -6.8% | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.9% | 2.0% | 0.9% | -0.2% | -2.5% | -2.5% | 1.3% | 3.1% | 0.1% | -2.7% | -9.6% | -7.6% | -6.9% | -29.4% | -2.0% |
| EBITDA | $13M | ($39M) | ($2M) | ($18M) | ($82M) | $46M | $35M | $38M | $32M | $27M | $25M | $4M | $8M | $8M | $5M | $2M | ($1M) | ($1M) | $0M | ($3M) | $0M |
| Earnings Per Share (EPS) | $-0.40 | $-0.84 | $-0.62 | $-0.70 | $-1.16 | $-0.07 | $0.04 | $0.08 | $0.03 | $-0.00 | $-0.02 | $-0.04 | $0.02 | $0.04 | $0.00 | $-0.03 | $-0.09 | $-0.06 | $-0.04 | $-0.11 | $-0.00 |
| Shares Outstanding (M) | 130M | 130M | 125M | 125M | 125M | 120M | 110M | 105M | 90M | 80M | — | 60M | 55M | 55M | 50M | 45M | 35M | 35M | 30M | 30M | 25M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M |
| Gross Profit | $92M | $81M | $76M | $80M | $77M | $73M | $77M | $75M |
| Gross Margin % | 45.6% | 43.3% | 39.8% | 42.8% | 42.6% | 43.6% | 44.9% | 44.6% |
| Operating Income (EBIT) | ($10M) | ($18M) | ($11M) | ($27M) | ($48M) | ($28M) | ($18M) | ($21M) |
| Operating Margin % | -4.9% | -9.8% | -5.9% | -14.4% | -26.3% | -16.6% | -10.7% | -12.6% |
| Net Income | $2M | ($17M) | ($10M) | ($27M) | ($45M) | ($26M) | ($15M) | ($18M) |
| Net Margin % | 1.1% | -9.2% | -5.2% | -14.4% | -24.9% | -15.4% | -8.9% | -10.5% |
| EBITDA | $19M | ($1M) | $5M | ($10M) | ($28M) | ($6M) | $4M | $2M |
| Earnings Per Share (EPS) | $0.02 | $-0.13 | $-0.08 | $-0.21 | $-0.35 | $-0.20 | $-0.12 | $-0.14 |
| Shares Outstanding (M) | 130M | 130M | 130M | 130M | 130M | 125M | 125M | 125M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $22M | $5M | $7M | ($2M) | ($66M) | ($27M) | $1M | $23M | $45M | $18M | $21M | $6M | $9M | $2M | $0M | $0M | ($2M) | ($2M) | $0M | ($3M) | ($1M) |
| Capital Expenditures (CapEx) | $29M | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | $2M | $4M | $1M | $1M | $1M | $1M | $1M | $0M |
| Free Cash Flow (FCF) | ($7M) | ($22M) | ($34M) | ($31M) | ($97M) | ($91M) | ($28M) | $3M | $30M | $4M | $14M | $4M | $6M | $0M | ($4M) | ($1M) | ($3M) | ($2M) | ($1M) | ($3M) | ($1M) |
| FCF Margin % | -0.9% | -3.0% | -5.1% | -5.2% | -19.0% | -18.8% | -6.2% | 0.8% | 11.0% | 1.8% | 5.7% | 4.2% | 6.5% | 0.3% | -6.9% | -1.9% | -8.6% | -8.4% | -3.2% | -27.5% | -16.9% |
| Dividends Paid | — | — | — | — | — | — | — | — | $10M | $0M | $88M | $0M | $0M | $0M | $0M | $0M | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $20M | ($8M) | $1M | $9M | $20M | ($25M) | $10M | $9M |
| Capital Expenditures (CapEx) | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M |
| Free Cash Flow (FCF) | $12M | ($13M) | ($7M) | $1M | $14M | ($30M) | ($2M) | ($2M) |
| FCF Margin % | 5.8% | -7.0% | -3.4% | 0.3% | 7.7% | -17.8% | -1.1% | -0.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.4B | $1.6B | $1.7B | $1.7B | $1.9B | $988M | $710M | $505M | $343M | $337M | $368M | $81M | $40M | $30M | $20M | $14M | $13M | $7M | $7M | $3M |
| Cash & Cash Equivalents | $146M | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | $5M | $2M | $3M | $1M | $2M | $0M | $0M | $0M |
| Total Liabilities | $566M | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $138M | $151M | $130M | $21M | $18M | $21M | $14M | $11M | $7M | $6M | $4M | $3M |
| Total Debt (Short + Long-Term) | $380M | $347M | $544M | $544M | $542M | $542M | $176M | $106M | $113M | $100M | $122M | $66M | $8M | $10M | $14M | $9M | $7M | $4M | $3M | $1M | $2M |
| Total Shareholders' Equity | $786M | $837M | $902M | $942M | $998M | $1.1B | $694M | $507M | $320M | $206M | $187M | $238M | $60M | $22M | $9M | $6M | $3M | $6M | $2M | $2M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NEO viewer.
About TickerBase · Data methodology & sources · Privacy · Terms